Jonathan Wolleben Stock Analyst Profile - JMP Securities Research Coverage - Stocknear

Jonathan Wolleben

Stock Analyst at JMP Securities

(5)
# 432
Out of 5,504 analysts
233
Total ratings
Success rate
Average return

31 Stocks

Name Action PT Current % Upside Ratings Updated
OCUL Ocular Therapeutix
Maintains: Market Outperform
20 29
11.4 154.39% 18 Oct 1, 2025
CRNX Crinetics Pharmaceut...
Maintains: Market Outperform
86 143
40.86 249.98% 16 Sep 26, 2025
RYTM Rhythm Pharmaceutica...
Maintains: Market Outperform
135 142
99.04 43.38% 5 Sep 25, 2025
KALV KalVista Pharmaceuti...
Maintains: Market Outperform
27 28
11.87 135.89% 5 Sep 12, 2025
MDGL Madrigal Pharmaceuti...
Maintains: Market Outperform
483 485
443.85 9.27% 13 Aug 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Market Outperform
18 18
4.87 269.61% 13 Aug 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Outperform
55 52
23.4 122.22% 12 Aug 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Outperform
25 26
7.5 246.67% 3 Aug 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Outperform
9 8
1.68 376.19% 2 Aug 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Outperform
67 69
64.83 6.43% 12 Aug 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Outperform
79 81
72.92 11.08% 11 Aug 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Outperform
89 87
27.25 219.27% 10 Aug 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Outperform
25 15
3.88 286.6% 13 Jul 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Market Outperform
8 8
2.45 226.53% 7 Jun 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Market Outperform
21 21
12.88 63.04% 15 Jun 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Market Outperform
15 15
4.73 217.12% 3 Jun 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Market Outperform
19 19
6.03 215.09% 9 May 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Market Outperform
75 75
4.3 1644.19% 11 May 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Outperform
38
16.67 127.95% 1 Apr 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Market Outperform
18 18
7.17 151.05% 8 Mar 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Market Outperform
9 9
3.48 158.62% 8 Dec 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Outperform
55 50
43.67 14.5% 1 Dec 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Market Outperform
90 90
84.8 6.13% 1 Dec 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Market Perform
n/a
n/a n/a 1 Dec 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
225 225
8.6 2516.28% 7 Dec 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Accumulate
420 485
682.68 -28.96% 1 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Market Outperform
3 3
n/a n/a 6 Sep 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Outperform
48 32
7.29 338.96% 8 Aug 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Market Outperform
8 8
0.55 1354.55% 11 Apr 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
25 24
33.86 -29.12% 1 May 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 May 25, 2021